CUBIST PHARMACEUTICALS INC's ticker is CBST and the CUSIP is 229678107. A total of 271 filers reported holding CUBIST PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 1.63 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $9,241,000 | -11.3% | 139,300 | -6.6% | 0.01% | -7.1% |
| Q2 2014 | $10,417,000 | +10.8% | 149,200 | +7.7% | 0.01% | +7.7% |
| Q1 2014 | $9,401,000 | +2.5% | 138,500 | +1.1% | 0.01% | 0.0% |
| Q4 2013 | $9,171,000 | -16.4% | 137,000 | -20.6% | 0.01% | -35.0% |
| Q3 2013 | $10,964,000 | +32.9% | 172,523 | +1.0% | 0.02% | +17.6% |
| Q2 2013 | $8,247,000 | – | 170,744 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 1,843,688 | $122,310,000 | 9.14% |
| HealthCor Management, L.P. | 1,100,000 | $72,974,000 | 3.75% |
| SECTOR GAMMA AS | 199,990 | $13,267,000 | 3.10% |
| AMI ASSET MANAGEMENT CORP | 365,309 | $24,235,000 | 2.38% |
| Redmile Group, LLC | 283,756 | $18,824,000 | 2.17% |
| EAGLE BOSTON INVESTMENT MANAGEMENT INC | 1,134,336 | $75,250,000 | 2.10% |
| PointState Capital LP | 1,650,000 | $109,461,000 | 1.98% |
| Tamarack Capital Management, LLC | 110,000 | $7,297,000 | 1.62% |
| Tekla Capital Management LLC | 494,454 | $32,802,000 | 1.54% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 3,421,430 | $226,978,000 | 1.39% |